Jim Simons’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-81,688
| Closed | -$302K | – | 3735 |
|
|
2017
Q4 | $302K | Buy |
81,688
+17,900
| +28% | +$73.3K | ﹤0.01% | 3023 |
|
|
2017
Q3 | $261K | Sell |
63,788
-5,800
| -8% | -$22.2K | ﹤0.01% | 2937 |
|
|
2017
Q2 | $259K | Buy |
69,588
+51,600
| +287% | +$205K | ﹤0.01% | 2940 |
|
|
2017
Q1 | $74K | Buy |
+17,988
| New | +$75.6K | ﹤0.01% | 3113 |
|
|
2015
Q4 | – | Sell |
-56,633
| Closed | -$931K | – | 3536 |
|
|
2015
Q3 | $931K | Sell |
56,633
-22,399
| -28% | -$459K | ﹤0.01% | 2418 |
|
|
2015
Q2 | $1.77M | Sell |
79,032
-23,331
| -23% | -$369K | ﹤0.01% | 2142 |
|
|
2015
Q1 | $1M | Buy |
+102,363
| New | +$1M | ﹤0.01% | 2309 |
|
|
2014
Q1 | – | Sell |
-26,117
| Closed | -$276K | – | 3131 |
|
|
2013
Q4 | $276K | Sell |
26,117
-91,777
| -78% | -$1.03M | ﹤0.01% | 2528 |
|
|
2013
Q3 | $1.46M | Buy |
117,894
+35,211
| +43% | +$371K | ﹤0.01% | 1820 |
|
|
2013
Q2 | $779K | Buy |
+82,683
| New | +$1.06M | ﹤0.01% | 2049 |
|
Jim Simons's CASC Position: Q1 2018 in Review
Jim Simons sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 81,688 shares — an estimated $302K sold.
Jim Simons first reported a position in CASC in Q2 2013 and held it in 10 quarters. The position peaked at $1.77M in Q2 2015. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.
- Jim Simons reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
- Jim Simons sold 81,688 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $302K.
- Jim Simons first reported a position in Cascadian Therapeutics, Inc. in Q2 2013 and held it in 10 quarters.
- Jim Simons's Cascadian Therapeutics, Inc. position peaked at $1.77M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.
Based on Renaissance Technologies's 13F filing for Q1 2018, filed 14 May 2018.